サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1392705

HPV関連疾患の世界市場レポート 2024年

HPV Associated Disorders Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
HPV関連疾患の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

HPV関連疾患市場規模は近年力強く成長しています。2023年の194億2,000万米ドルから2024年には209億7,000万米ドルに、CAGR8.0％で拡大します。この期間の拡大は、HPV関連疾患の有病率の増加、HPVとその関連疾患に対する意識の高まり、診断技術の進歩、HPVワクチン接種プログラムを推進する政府の取り組み、早期スクリーニングとワクチン接種の需要の高まりに起因しています。

2023年のHPV関連疾患市場では北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。HPV関連疾患市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 HPV関連疾患市場の特徴

第3章 HPV関連疾患市場の動向と戦略

第4章 HPV関連疾患市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のHPV関連疾患市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年から2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 HPV関連疾患市場セグメンテーション

  • 世界のHPV関連疾患市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F
  • 子宮頸部上皮内腫瘍（CIN）
  • 子宮頸がん
  • 肛門上皮内腫瘍（AIN）
  • 肛門がん
  • 性器いぼ
  • その他の適応症
  • 世界のHPV関連疾患市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F
  • 予防
  • 治療
  • 世界のHPV関連疾患市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 HPV関連疾患市場の地域および国分析

  • 世界のHPV関連疾患市場、地域別、実績および予測、2018年から2023年、2023年から2028年まで、2033年まで
  • 世界のHPV関連疾患市場、国別、実績および予測、2018年から2023年、2023年から2028年まで、2033年まで

第8章 アジア太平洋のHPV関連疾患市場

  • 概要
  • 地域情報、COVID-19症の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • 適応症別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 治療別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F

第9章 中国のHPV関連疾患市場

第10章 インドのHPV関連疾患市場

第11章 日本のHPV関連疾患市場

第12章 オーストラリアのHPV関連疾患市場

第13章 インドネシアのHPV関連疾患市場

第14章 韓国のHPV関連疾患市場

第15章 西欧のHPV関連疾患市場

  • 概要
  • 適応症別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 治療別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F

第16章 英国のHPV関連疾患市場

第17章 ドイツのHPV関連疾患市場

第18章 フランスのHPV関連疾患市場

第19章 イタリアのHPV関連疾患市場

第20章 スペインのHPV関連疾患市場

第21章 東欧のHPV関連疾患市場

  • 概要
  • 適応症別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 治療別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F

第22章 ロシアのHPV関連疾患市場

第23章 北米のHPV関連疾患市場

  • 概要
  • 適応症別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 治療別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F

第24章 米国のHPV関連疾患市場

第25章 カナダのHPV関連疾患市場

第26章 南米のHPV関連疾患市場

  • 概要
  • 適応症別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 治療別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F

第27章 ブラジルのHPV関連疾患市場

第28章 中東のHPV関連疾患市場

  • 概要
  • 適応症別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 治療別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F

第29章 アフリカのHPV関連疾患市場

  • 概要
  • 適応症別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 治療別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028F、2033F

第30章 HPV関連疾患市場の競合情勢と企業プロファイル

  • HPV関連疾患市場の競合情勢
  • HPV関連疾患市場の企業プロファイル
    • AstraZeneca plc
    • F. Hoffmann-La Roche Ltd
    • Biocon Ltd
    • GlaxoSmithKline plc
    • Merck & Co Inc

第31章 世界のHPV関連疾患市場の競合ベンチマーキング

第32章 世界のHPV関連疾患市場競争ダッシュボード

第33章 HPV関連疾患市場における主要な合併と買収

第34章 HPV関連疾患市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10393

“HPV Associated Disorders Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hpv associated disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hpv associated disorders? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hpv associated disorders market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Indication: Cervical Intraepithelial Neoplasia (CIN); Cervical Cancer; Anal Intraepithelial Neoplasia (AIN); Anal Cancer; Genital Warts; Other Indications
  • 2) By Therapy: Prevention; Treatment
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: AstraZeneca plc; F. Hoffmann-La Roche Ltd; Biocon Ltd; GlaxoSmithKline plc; Merck & Co Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

The disorders associated with the human papillomavirus pertain to a virus capable of triggering abnormal tissue growth, such as warts and various cell irregularities. Transmission of these disorders primarily occurs through sexual intercourse or other forms of skin-to-skin contact. Vaccination, medications, and other diagnostic measures can aid in safeguarding against HPV types that lead to HPV-related cancer.

The primary manifestations of HPV-associated disorders include cervical intraepithelial neoplasia (CIN), cervical cancer, anal intraepithelial neoplasia (AIN), anal cancer, genital warts, and other indications. The cervical intraepithelial indication of HPV-associated disorder is employed for the prevention and treatment of cervical intraepithelial neoplasia. Cervical intraepithelial neoplasia (CIN) denotes abnormal alterations in the cells lining the cervix. The management of HPV-associated disorders involves preventive and therapeutic measures, which are accessible through hospital pharmacies, retail pharmacies, and online pharmacies.

The HPV associated disorders market research report is one of a series of new reports from The Business Research Company that provides HPV associated disorders market statistics, including HPV associated disorders industry global market size, regional shares, competitors with a HPV associated disorders market share, detailed HPV associated disorders market segments, market trends and opportunities, and any further data you may need to thrive in the HPV associated disorders industry. This HPV associated disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hpv associated disorders market size has grown strongly in recent years. It will grow from $19. 42 billion in 2023 to $20. 97 billion in 2024 at a compound annual growth rate (CAGR) of 8. 0%. The expansion during the historical period can be ascribed to the increasing prevalence of HPV-associated disorders, a heightened awareness of HPV and its related conditions, advancements in diagnostic technologies, government initiatives promoting HPV vaccination programs, and a growing demand for early screening and vaccination.

The hpv associated disorders market size is expected to see strong growth in the next few years. It will grow to $27. 82 billion in 2028 at a compound annual growth rate (CAGR) of 7. 3%. The anticipated growth in the forecast period can be linked to the approval of new HPV vaccines, heightened initiatives by both government and private organizations for early screening and vaccination, an upsurge in the incidence of cervical cancer, an increasing demand for non-invasive diagnostic tests, and the integration of HPV testing into routine healthcare. Prominent trends expected in the forecast period encompass the development of next-generation HPV vaccines, the adoption of point-of-care HPV testing, a shift towards molecular techniques in HPV detection, personalized approaches in HPV management, and the integration of HPV testing within women's health services.

The HPV-associated disorders market is expected to witness growth due to an increased prevalence of HPV-related cases. These disorders encompass a range from benign verrucae vulgates and condylomas acuminata to malignancies such as cervical, vulva, anus, and penis cancers, as well as anogenital warts, recurrent respiratory papillomatosis, and anogenital and oropharyngeal cancers. The global burden is significant, particularly among women. For instance, a report from cancer. net in January 2022 estimated that 14,100 women in the United States would be diagnosed with invasive cervical cancer, and globally, 604,127 women were diagnosed with cervical cancer in 2020. Additionally, in 2023, an estimated 4,310 deaths from cervical cancer occurred in the United States, emphasizing the need for advancements in the HPV-associated disorders market.

A driving factor in the HPV-associated disorders market is the decline in contraceptive use. Contraceptives play a crucial role in preventing unplanned pregnancies, and a reduction in their market share can lead to an increase in the number of individuals at risk of HPV infection, a known risk factor for disorders like cervical cancer. A report in December 2022 revealed an 8% reduction in the overall value of the public-sector contraceptive market across 83 Low and Middle-Income Countries (LMICs). This decline, from $285 million in 2020 to $263 million in 2021, underscores the impact on the HPV-associated disorders market.

A notable trend in the HPV-associated disorders market is the growing popularity of targeted therapies. Key players are developing and adopting therapies specifically designed to treat HPV-associated disorders, including cervical and oropharyngeal cancers. These targeted therapies focus on proteins like vascular endothelial growth factor and tissue-factor (TF) in cancer cells. An example is the FDA approval of Genmab A/S and Seagen Inc. 's drug Tivdak (tisotumab vedotin-tftv) in September 2021 for recurrent or metastatic cervical cancer post-chemotherapy, indicating a shift toward more effective treatment options.

Leading companies in the HPV-associated disorders market are introducing gender-neutral HPV vaccines to combat HPV-related diseases. These vaccines are recommended and administered to individuals of all genders to protect against HPV, which can lead to various cancers. In September 2021, MSD Pharmaceuticals launched GARDASIL 9, the first gender-neutral HPV vaccine in India, aiming to reduce HPV-related diseases and cancers in both girls and women (aged 9-26 years) and boys (aged 9-15 years). This vaccine, a 9-valent Human Papillomavirus (HPV) vaccine, is designed to prevent diseases and cancers caused by specific HPV types, with dosing schedules determined by healthcare professionals.

In May 2022, GlaxoSmithKline plc, a UK-based biopharmaceutical company, acquired Affinivax, Inc. for $2. 1 billion. This strategic acquisition enhances GSK plc's vaccine R&D pipeline by providing access to Affinivax's innovative vaccine technology platform, MAPS (Multiple Antigen Presenting System). Affinivax, Inc., a US-based clinical-stage biopharmaceutical company, specializes in developing next-generation vaccine technology platforms.

Major companies operating in the in the hpv associated disorders market report are AstraZeneca plc, F. Hoffmann-La Roche Ltd, Biocon Ltd, GlaxoSmithKline plc, Merck & Co Inc., Pfizer Inc., Eli Lilly and Company, Sanofi S. A., Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Celgene Corporation, Gilead Sciences Inc., Ipsen S. A., Mylan N. V., Teva Pharmaceutical Industries Ltd., Bayer AG, Eisai Co. Ltd., Genentech Inc., Medtronic plc, Novo Nordisk A/S, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, CSL Limited, Lupin Limited

North America was the largest region in the HPV associated disorders market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hpv associated disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hpv associated disorders market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The human papillomavirus-associated disorders market includes revenues earned by entities by plantar warts and flat warts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. HPV Associated Disorders Market Characteristics

3. HPV Associated Disorders Market Trends And Strategies

4. HPV Associated Disorders Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global HPV Associated Disorders Market Size and Growth

  • 5.1. Global HPV Associated Disorders Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global HPV Associated Disorders Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global HPV Associated Disorders Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. HPV Associated Disorders Market Segmentation

  • 6.1. Global HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cervical Intraepithelial Neoplasia (CIN)
  • Cervical Cancer
  • Anal Intraepithelial Neoplasia (AIN)
  • Anal Cancer
  • Genital Warts
  • Other Indications
  • 6.2. Global HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prevention
  • Therapy
  • 6.3. Global HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. HPV Associated Disorders Market Regional And Country Analysis

  • 7.1. Global HPV Associated Disorders Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global HPV Associated Disorders Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific HPV Associated Disorders Market

  • 8.1. Asia-Pacific HPV Associated Disorders Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China HPV Associated Disorders Market

  • 9.1. China HPV Associated Disorders Market Overview
  • 9.2. China HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India HPV Associated Disorders Market

  • 10.1. India HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan HPV Associated Disorders Market

  • 11.1. Japan HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia HPV Associated Disorders Market

  • 12.1. Australia HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia HPV Associated Disorders Market

  • 13.1. Indonesia HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea HPV Associated Disorders Market

  • 14.1. South Korea HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe HPV Associated Disorders Market

  • 15.1. Western Europe HPV Associated Disorders Market Overview
  • 15.2. Western Europe HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK HPV Associated Disorders Market

  • 16.1. UK HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany HPV Associated Disorders Market

  • 17.1. Germany HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France HPV Associated Disorders Market

  • 18. 5. France HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy HPV Associated Disorders Market

  • 19. 9. Italy HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain HPV Associated Disorders Market

  • 20.13. Spain HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe HPV Associated Disorders Market

  • 21.1. Eastern Europe HPV Associated Disorders Market Overview
  • 21.2. Eastern Europe HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia HPV Associated Disorders Market

  • 22.1. Russia HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America HPV Associated Disorders Market

  • 23.1. North America HPV Associated Disorders Market Overview
  • 23.2. North America HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA HPV Associated Disorders Market

  • 24.1. USA HPV Associated Disorders Market Overview
  • 24.2. USA HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada HPV Associated Disorders Market

  • 25.1. Canada HPV Associated Disorders Market Overview
  • 25.2. Canada HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America HPV Associated Disorders Market

  • 26.1. South America HPV Associated Disorders Market Overview
  • 26.2. South America HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil HPV Associated Disorders Market

  • 27.1. Brazil HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East HPV Associated Disorders Market

  • 28.1. Middle East HPV Associated Disorders Market Overview
  • 28.2. Middle East HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa HPV Associated Disorders Market

  • 29.1. Africa HPV Associated Disorders Market Overview
  • 29.2. Africa HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. HPV Associated Disorders Market Competitive Landscape And Company Profiles

  • 30.1. HPV Associated Disorders Market Competitive Landscape
  • 30.2. HPV Associated Disorders Market Company Profiles
    • 30.2.1. AstraZeneca plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Biocon Ltd
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. GlaxoSmithKline plc
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. Merck & Co Inc
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global HPV Associated Disorders Market Competitive Benchmarking

32. Global HPV Associated Disorders Market Competitive Dashboard

33. Key Mergers And Acquisitions In The HPV Associated Disorders Market

34. HPV Associated Disorders Market Future Outlook and Potential Analysis

  • 34.1 HPV Associated Disorders Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 HPV Associated Disorders Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 HPV Associated Disorders Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer